Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 06 Jul 2026 for Insight Molecular Diagnostics Inc., €39k. Read the official filing
Filing timeline
BuySaleAndrew J. Last
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Andrew J. Last: trading record in brief
Andrew J. Last is a declared insider at 3 companies (senior executive); the most frequent names are Bio-Rad Laboratories, Inc., Insight Molecular Diagnostics Inc. and Affymetrix Inc. We count 19 filings; the first trade dates from 8 February 2016 and the latest from 1 July 2026.
The open-market side counts 1 purchase for €17k alongside 1 sale for €891k. Sales outweigh purchases by €874k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 7 share grants and 10 option exercises.
On 6 July 2026 came the latest disclosure, a share grant for €39k in Insight Molecular Diagnostics Inc. The clock since the last published purchase (19 August 2022) now reads 1,521 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew J. Last
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
7,700 shares@ US$5.69100.0% of flowCommon Stock, no par valueSEC:0001493152-26-032233:0
35,000 shares0Common Stock, no par valueSEC:0001641172-25-017787:0
3,000 shares@ US$299.2428.8% of flowBio-Rad A Common StockSEC:0001062993-24-016386:0
3,000 shares@ US$329.938431.8% of flowBio-Rad A Common StockSEC:0001062993-24-016386:1
1,252 shares0Bio-Rad A Common StockSEC:0001062993-24-016169:0
357 shares@ US$277.113.3% of flowBio-Rad A Common StockSEC:0001062993-24-009082:1
1,000 shares0Bio-Rad A Common StockSEC:0001062993-24-009082:0
867 shares0Bio-Rad A Common StockSEC:0001062993-23-017654:0
20,000 shares0Common Stock, no par valueSEC:0001493152-23-022669:0
1,000 shares0Bio-Rad A Common StockSEC:0001062993-23-009749:0
902 shares0Bio-Rad A Common StockSEC:0001062993-22-019282:0
633 shares0Bio-Rad A Common StockSEC:0001062993-22-019194:0
20,000 shares@ US$0.8733.1% of flowCommon Stock, no par valueSEC:0001493152-22-023524:0
Canonical exit: 15 Nov 2022 (T+90)
10,000 shares0Common Stock, no par valueSEC:0001493152-22-023385:0
10,000 shares0Common Stock, no par valueSEC:0001493152-22-019822:0
1,000 shares0Bio-Rad A Common StockSEC:0001062993-22-011169:0
2,000 shares@ US$299.2422.0% of flowBio-Rad A Common StockSEC:0001062993-21-008244:0
6,993 shares@ US$3.0050.2% of flowCommon StockSEC:0001493152-21-014342:0
37,297 sharesCommon StockSEC:0001140361-16-051546:0
19 of 19 declarations
